Javascript must be enabled to continue!
Repeat Hepatectomy for Recurrent Colorectal Metastases
View through CrossRef
AbstractRecurrence rates after hepatic resection in patients with colorectal metastases are reported to range from 47% to 80%. Hepatic recurrence is seen in 35% to 50% of patients. Aggressive surgical resection appears to be a worthwhile treatment in patients with recurrent hepatic metastases to promote longer patient survival because surgical resection remains the only curative therapy available. This is a retrospective review of our experience with 15 patients undergoing repeat hepatic resection culled from 67 patients undergoing initial hepatectomy for metastatic colorectal cancer. Of 67 patients who underwent hepatectomy for colorectal hepatic metastases, 33 developed hepatic recurrence at a median interval of 23 months (range 1–176 months) after the first hepatectomy. The second hepatectomy was performed in 15 patients 5 to 29 months after the first hepatectomy, with no mortality. The mean operating time and blood loss at the second hepatectomy were similar to those at the first hepatectomy. The mean hospital stay at the second hepatectomy was significantly shorter than that at the first hepatectomy. The cumulative survival rate for the 15 patients was 42.4% at 3 years and 21.2% at 5 years, respectively, which compared favorably with the survival rate of the 67 patients who underwent initial hepatectomy. Patients who underwent the second hepatectomy had significantly higher survival rates from the first hepatectomy than the 18 patients with unresectable hepatic recurrence. Repeat hepatectomy can be performed safely and provides long‐term survival rates similar to those of first hepatectomies. In appropriately selected patients, repeat hepatectomy for colorectal metastases is a worthwhile treatment.
Title: Repeat Hepatectomy for Recurrent Colorectal Metastases
Description:
AbstractRecurrence rates after hepatic resection in patients with colorectal metastases are reported to range from 47% to 80%.
Hepatic recurrence is seen in 35% to 50% of patients.
Aggressive surgical resection appears to be a worthwhile treatment in patients with recurrent hepatic metastases to promote longer patient survival because surgical resection remains the only curative therapy available.
This is a retrospective review of our experience with 15 patients undergoing repeat hepatic resection culled from 67 patients undergoing initial hepatectomy for metastatic colorectal cancer.
Of 67 patients who underwent hepatectomy for colorectal hepatic metastases, 33 developed hepatic recurrence at a median interval of 23 months (range 1–176 months) after the first hepatectomy.
The second hepatectomy was performed in 15 patients 5 to 29 months after the first hepatectomy, with no mortality.
The mean operating time and blood loss at the second hepatectomy were similar to those at the first hepatectomy.
The mean hospital stay at the second hepatectomy was significantly shorter than that at the first hepatectomy.
The cumulative survival rate for the 15 patients was 42.
4% at 3 years and 21.
2% at 5 years, respectively, which compared favorably with the survival rate of the 67 patients who underwent initial hepatectomy.
Patients who underwent the second hepatectomy had significantly higher survival rates from the first hepatectomy than the 18 patients with unresectable hepatic recurrence.
Repeat hepatectomy can be performed safely and provides long‐term survival rates similar to those of first hepatectomies.
In appropriately selected patients, repeat hepatectomy for colorectal metastases is a worthwhile treatment.
Related Results
The incidence and outcome of brain metastases after liver resection for colorectal cancer metastases
The incidence and outcome of brain metastases after liver resection for colorectal cancer metastases
AbstractAim Brain metastases from colorectal cancer are rare, with an incidence of 0.6–4%. The risk and outcome of brain metastases after hepatic and pulmonary metastasectomy have...
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
Local treatment of colorectal pulmonary metastases
Local treatment of colorectal pulmonary metastases
In this thesis the role of local therapy for pulmonary oligometastases in colorectal cancer patients is described. In the introduction, Chapter 1, the theory and basis for the olig...
Caudate lobe-based minimally invasive anatomic hepatectomy: a retrospective study
Caudate lobe-based minimally invasive anatomic hepatectomy: a retrospective study
Abstract
Background: Anatomic hepatectomy has become a crucial surgical procedure in the liver section. The function and role of the caudate lobe in anatomic hepatectomy re...
Risk Factors of Post-Partial Hepatectomy Acute Myocardial Infarction : A Retrospective Nationwide Inpatient Sample Database Study
Risk Factors of Post-Partial Hepatectomy Acute Myocardial Infarction : A Retrospective Nationwide Inpatient Sample Database Study
Abstract
Background
The aftermath of partial hepatectomy often results in a severe condition known as acute myocardial infarction (AMI), which may lead to death and frequen...
RAS mutation nomograms to predict prognosis after radiofrequency ablation of recurrent colorectal liver metastases
RAS mutation nomograms to predict prognosis after radiofrequency ablation of recurrent colorectal liver metastases
Abstract
Objectives: This study was conducted to develop nomograms for predicting repeat intrahepatic recurrence (rIHR) and overall survival (OS) after radiofrequency ablat...
Long-term outcome following microwave ablation of lung metastases from colorectal cancer
Long-term outcome following microwave ablation of lung metastases from colorectal cancer
PurposeTo retrospectively evaluate the safety and efficacy of percutaneous computed tomography (CT)-guided microwave ablation (MWA) in colorectal cancer (CRC) lung metastases, and ...
Immunohistochemistry expression of TCF4 protein on carcinoma, adenoma and non neoplastic colorectal mucosa
Immunohistochemistry expression of TCF4 protein on carcinoma, adenoma and non neoplastic colorectal mucosa
AbstractPurpose To detect and quantify the immunoreactivity of TCF4 protein in colorectal carcinoma, colorectal adenoma and non-neoplasic colorectal epithelium.Methods We studied 1...

